JP2009541437A5 - - Google Patents

Download PDF

Info

Publication number
JP2009541437A5
JP2009541437A5 JP2009517174A JP2009517174A JP2009541437A5 JP 2009541437 A5 JP2009541437 A5 JP 2009541437A5 JP 2009517174 A JP2009517174 A JP 2009517174A JP 2009517174 A JP2009517174 A JP 2009517174A JP 2009541437 A5 JP2009541437 A5 JP 2009541437A5
Authority
JP
Japan
Prior art keywords
pain
amino
hydroxymethyl
cancer
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009517174A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009541437A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/056377 external-priority patent/WO2008000744A2/en
Publication of JP2009541437A publication Critical patent/JP2009541437A/ja
Publication of JP2009541437A5 publication Critical patent/JP2009541437A5/ja
Withdrawn legal-status Critical Current

Links

JP2009517174A 2006-06-27 2007-06-26 治療用化合物 Withdrawn JP2009541437A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0601397 2006-06-27
US83740206P 2006-08-11 2006-08-11
PCT/EP2007/056377 WO2008000744A2 (en) 2006-06-27 2007-06-26 2-0'-methyladen0sine derivatives and their use as agonists or antagonists of an adenosine receptor

Publications (2)

Publication Number Publication Date
JP2009541437A JP2009541437A (ja) 2009-11-26
JP2009541437A5 true JP2009541437A5 (https=) 2010-08-05

Family

ID=38573394

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009517174A Withdrawn JP2009541437A (ja) 2006-06-27 2007-06-26 治療用化合物

Country Status (10)

Country Link
US (1) US7820811B2 (https=)
EP (1) EP2081932A2 (https=)
JP (1) JP2009541437A (https=)
CN (1) CN101479268B (https=)
AU (1) AU2007263727A1 (https=)
BR (1) BRPI0713902A2 (https=)
CA (1) CA2654371A1 (https=)
NZ (1) NZ573307A (https=)
RU (1) RU2009102536A (https=)
WO (1) WO2008000744A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007263728A1 (en) * 2006-06-27 2008-01-03 Biovitrum Ab (Publ) Adenosine derivatives for the treatment of pain
WO2012048013A2 (en) * 2010-10-06 2012-04-12 Inhibitex, Inc. Phosphorodiamidate derivatives of guanosine nucleoside compounds for treatment of viral injections

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843066A (en) 1986-11-27 1989-06-27 Nippon Zoki Pharmaceutical Co., Ltd. Novel adenosine derivatives and pharmaceutical composition containing them as an active ingredient
US5968914A (en) 1987-10-28 1999-10-19 Pro-Neuron, Inc. Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
ATE269870T1 (de) * 1989-10-24 2004-07-15 Isis Pharmaceuticals Inc 2'-modifizierte oligonukleotide
HUT61567A (en) 1990-12-07 1993-01-28 Sandoz Ag Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate
EP0601322A3 (en) 1992-10-27 1994-10-12 Nippon Zoki Pharmaceutical Co Adenosine deaminase inhibitor.
US5877180A (en) 1994-07-11 1999-03-02 University Of Virginia Patent Foundation Method for treating inflammatory diseases with A2a adenosine receptor agonists
ATE236922T1 (de) 1997-06-03 2003-04-15 Itochu Techno Chem Inc Natürliche antitumor- oder antivirale substanzen und ihre anwendung
US6576619B2 (en) 1999-05-24 2003-06-10 Cv Therapeutics, Inc. Orally active A1 adenosine receptor agonists
MXPA04012779A (es) 2002-06-28 2005-08-19 Idenix Cayman Ltd Profarmacos de 2'- y 3'-nucleosido para tratar infecciones por flaviviridae.
GB0228723D0 (en) 2002-12-09 2003-01-15 Cambridge Biotechnology Ltd Treatment of pain
GB0305150D0 (en) 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Use of therapeutic compounds
GB0305153D0 (en) 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Identification of therapeutic compounds
GB0305149D0 (en) 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Compounds for the treatment of pain
GB0328323D0 (en) 2003-12-05 2004-01-07 Cambridge Biotechnology Ltd Synthesis of 2-substituted adenosines
CA2557285A1 (en) * 2004-03-05 2005-09-15 Cambridge Biotechnology Limited Adenosine receptor agonists
AU2007263728A1 (en) * 2006-06-27 2008-01-03 Biovitrum Ab (Publ) Adenosine derivatives for the treatment of pain

Similar Documents

Publication Publication Date Title
AU2020286299B2 (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
NL2000323C2 (nl) Pyrimidine-derivaten.
KR102327464B1 (ko) 인플루엔자 rna 복제의 저해제로서의 4'-다이플루오로메틸 치환된 뉴클레오사이드 유도체
JP2009541436A5 (https=)
JP4125790B2 (ja) トリアゾロ［４，５−ｄ］ピリミジニル誘導体および医薬としてのその使用
CZ20023992A3 (cs) Purinové deriváty
JP2007526291A5 (https=)
US6713483B1 (en) [1,2,3]-triazolo[4,5-d] pyrimidine compounds
JP2005534684A5 (https=)
CZ20023875A3 (cs) 2-Aminokarbonyl-9H-purinové deriváty
WO2008124085A2 (en) Methods of using combinations of mek and jak-2 inhibitors
JP2005194283A5 (https=)
RU2009102512A (ru) Терапевтические соединения
AU2016298355A1 (en) Respiratory syncytial virus inhibitors
IL297041A (en) Inhibitors of human immunodeficiency virus replication
JP2009541437A5 (https=)
WO2016049415A1 (en) 4'-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus rna replication
RU2009102531A (ru) Терапевтические соединения
SK14052003A3 (sk) Použitie derivátov adenozínu na prípravu liečiva na liečenie syndrómu inzulínovej rezistencie a diabetu
JP7522414B2 (ja) Ｊａｋキナーゼ阻害剤、その調製および適用
RU2009102536A (ru) Терапевтические соединения
JPH05507267A (ja) カルボ―ヌクレオシド誘導体
US20190323012A1 (en) TNF-Alpha-Binding Aptamer, And Therapeutic Use For Same
US20080194635A1 (en) Crystalline Forms of Cis-5-Fluoro-N-[4-(2-Hydroxy-4-Methylbenzamido) Cyclohexyl]-2-(Tetrahydrothiopyran-4-Yloxy) Nicotinamide
TW202547514A (zh) 人類免疫不全病毒複製之抑制劑